Stock listing
RARE Stock Price, News, Filings & Events — Ultragenyx Pharmaceutical Inc.
Selected listing: RARE · BMV · MXN · MX
This page tracks Ultragenyx Pharmaceutical Inc.'s RARE:BMV listing on BMV in MXN for MX, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following RARE:BMV. RARE:BMV is the stock-level entry point for investors researching Ultragenyx Pharmaceutical Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Ultragenyx Pharmaceutical Inc. is a public company traded under the ticker RARE in the American market. The company has a market capitalization of approximately $2.88 billion. Ultragenyx focuses on developing innovative treatments for rare and ultra-rare genetic diseases.
- Ticker
- RARE:BMV
- Asset type
- Stock
- Market cap
- $2.45B
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- BMV
- Currency
- MXN
Ultragenyx Pharmaceutical Inc. RARE:BMV stock context
This page tracks Ultragenyx Pharmaceutical Inc.'s RARE:BMV listing on BMV in MXN for MX, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following RARE:BMV. RARE:BMV is the stock-level entry point for investors researching Ultragenyx Pharmaceutical Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Ultragenyx Pharmaceutical Inc. is a public company traded under the ticker RARE in the American market. The company has a market capitalization of approximately $2.88 billion. Ultragenyx focuses on developing innovative treatments for rare and ultra-rare genetic diseases.
Latest news from Ultragenyx Pharmaceutical Inc.
Ultragenyx Announces U.S. FDA Approval of GENGLYCOS Gene Therapy, the First-Ever FDA-Approved Treatment Designed to Treat the Underlying ...
August 20, 2026
Ultragenyx Announces U.S. FDA Approval of GENGLYCOS™ Gene Therapy, the First-Ever FDA-Approved Treatment Designed to Treat the Underlying...
August 19, 2026
Ultragenyx Reports Second Quarter 2026 Financial Results and Corporate Update
August 4, 2026
Ultragenyx to Host Conference Call for Second Quarter 2026 Financial Results and Corporate Update
July 28, 2026
Ultragenyx Releases 2025 Impact Report Emphasizing Commitment to Rare Disease Patients, Innovation, and Global Impact
July 8, 2026
Ultragenyx Pharmaceutical Inc. earnings calls
Ultragenyx Pharmaceutical Inc. (RARE) Q2 2026 Earnings Call
August 4, 2026 · Replay with transcript and chapters
Ultragenyx Pharmaceutical Inc. (RARE) Q1 2026 Earnings Call
May 5, 2026 · Replay with transcript and chapters
Ultragenyx Pharmaceutical Inc. (RARE) Q4 2025 Earnings Call
February 12, 2026 · Replay with transcript and chapters
Ultragenyx Pharmaceutical Inc. (RARE) Q3 2025 Earnings Call
November 4, 2025 · Replay with transcript and chapters
Ultragenyx Pharmaceutical Inc. (RARE) Q2 2025 Earnings Call
August 5, 2025 · Replay with transcript and chapters
Ultragenyx Pharmaceutical Inc. (RARE) Q1 2025 Earnings Call
May 6, 2025 · Replay with transcript and chapters
Research Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc. investor report
Review AI stock analysis and investor report context for RARE:BMV.
Ultragenyx Pharmaceutical Inc. company profile
View the public company page for Ultragenyx Pharmaceutical Inc. on 6ix.
Ultragenyx Pharmaceutical Inc. news
Read company news and market updates connected to Ultragenyx Pharmaceutical Inc..
Ultragenyx Pharmaceutical Inc. investor events
Find investor webinars, events, and replay context for Ultragenyx Pharmaceutical Inc..
Alternate listings
RARE:NASDAQ
US · USD
Alternate listing for Ultragenyx Pharmaceutical Inc.; the primary context on this page is RARE:BMV.
0LIF:LSE
GB · USD
Alternate listing for Ultragenyx Pharmaceutical Inc.; the primary context on this page is RARE:BMV.
UP0:GETTEX
DE · EUR
Alternate listing for Ultragenyx Pharmaceutical Inc.; the primary context on this page is RARE:BMV.
A1XCY0:LSX
DE · EUR
Alternate listing for Ultragenyx Pharmaceutical Inc.; the primary context on this page is RARE:BMV.
A1XCY0:LS
DE · EUR
Alternate listing for Ultragenyx Pharmaceutical Inc.; the primary context on this page is RARE:BMV.
R2AR34:BMFBOVESPA
BR · BRL
Alternate listing for Ultragenyx Pharmaceutical Inc.; the primary context on this page is RARE:BMV.
RARE:BIVA
MX · MXN
Alternate listing for Ultragenyx Pharmaceutical Inc.; the primary context on this page is RARE:BMV.
UP0:FWB
DE · EUR
Alternate listing for Ultragenyx Pharmaceutical Inc.; the primary context on this page is RARE:BMV.
UP0:TRADEGATE
DE · EUR
Alternate listing for Ultragenyx Pharmaceutical Inc.; the primary context on this page is RARE:BMV.
RARE:BOATS
US · USD
Alternate listing for Ultragenyx Pharmaceutical Inc.; the primary context on this page is RARE:BMV.
UP0:BX
CH · CHF
Alternate listing for Ultragenyx Pharmaceutical Inc.; the primary context on this page is RARE:BMV.
UP0:DUS
DE · EUR
Alternate listing for Ultragenyx Pharmaceutical Inc.; the primary context on this page is RARE:BMV.